PGC-1α inhibits oleic acid induced proliferation and migration of rat vascular smooth muscle cells

PLoS ONE

Volumn 2, Issue 11, 2007, Pages

  Zhang, Yan ^a   Liu, Chang ^a   Zhu, Lingyun ^a   Jiang, Xiaohong ^a   Chen, Xi ^a   Qi, Xiaoqiang ^a   Liang, Xiangying ^a   Jin, Sonia ^b   Zhang, Peixiang ^a   Li, Qingguo ^c   Wang, Dongjin ^c   Liu, Xiaofeng ^a   Zeng, Ke ^a   Zhang, Junfeng ^a   Xiang, Yang ^a   Zhang, Chen Yu ^a  

^a NANJING UNIVERSITY   (China)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SMALL INTERFERING RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1, RAT; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR-1, RAT; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA ATHEROSCLEROSIS; AORTA MEDIA; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; UPREGULATION; ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

RATTUS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MUSCLE, SMOOTH, VASCULAR; OLEIC ACID; RATS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 42649104789     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001137     Document Type: Article

References (50)

1. Schwartz SM, deBlois D, O'Brien ERM (1995) The intima: soil for atherosclerosis and restenosis. Circ Res 77: 445-465.
2. Newby AC, Zaltsman AB (2000) Molecular mechanisms in intimal hyperplasia. J Pathol 190: 300-309.
3. Peiris A, Sothmann M, Hoffmann R, Hennes M, Wilson C, et al. (1989) Adiposity, fat distribution and cardiovascular risk. Ann Intern Med 110: 867-872.
4. Egan BM, Hennes MM, Stepniakowski KT, O'Shaughnessy IM, Kissebah AH, et al. (1996) Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension 27(3 Pt 2): 723-728.
5. Hennes MM, O'Shaughnessy IM, Kelly TM, Labelle P, Egan BM, et al. (1996) Insulin-resistant lipolysis in abdominally obese hypertensives: role of the reninangiotensin system. Hypertension 28: 120-126.
6. Egan BM, Lu G, Greene EL (1999) Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor duster. Prostaglandins Leukot Essent Fatty Acids 60(5-6): 411-420.
7. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
8. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, et al. (1995) Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 26: 764-770.
9. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM (1996) Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C. Circ Res 79: 611-618.
10. Lu G, Greene EL, Nagai T, Egan BM (1998) Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 32: 1003-1010.
11. Greene EL, Lu G, Zhang D, Egan BM (2001) Signaling events mediating the additive effects of OA and angiotensin II on vascular smooth muscle cell, migration. Hypertension 37: 308-312.
12. Hsueh WA, Law RE (2001) PPARγ and atherosclerosis. Effects on cell growth and movement. Arterioscler Thromb Vasc Biol 21: 1891-1895.
13. Wakino S, Kintscher U, Kim S, Yin F, Hsueh WA, et al. (2000) Peroxisome proliferator-activated receptor- ligands inhibit Rb phosphorylation and G13S transition in vascular smooth muscle cells. J Biol Chem 275: 22435-22441.
14. Goetze S, Kintscher U, Kim S, Meehan WP, Kaneshiro K, et al. (2001) PPARγ-ligands inhibit nuclear but not cytosolic ERK MAPK-regulated steps in vascular smooth muscle cell migration. J Cardiovasc Pharmacol 38: 909-921.
15. Collins AR, Meehan WP, Kinstcher U, Jackson S, Wakinco S, et al. (2001) Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arteriosder Thromb Vasc Biol 21: 365-371.
16. Puigserver P, Wu Z, Park CW, Graves R, Wright M, et al. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839.
17. Puigserver P, Spiegelman BM (2003) Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocrine Reviews 24: 78-90.
18. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124.
19. Larrouy D, Vidal H, Andreelli F, Laville M, Langin D (1999) Cloning and mRNA tissue distribution of human PPARgamma coactivator-1. Int J Obes Relat Metab Disord 23: 1327-1332.
20. Esterbauer H, Oberkofler H, Krempler F, Patsch W (1999) Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 62: 98-102.
21. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, et al. (2002) Transcriptional coactivator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
22. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131-138.
23. Yoon JC, Xu G, Deeney JT, Yang SN, Rhee J, et al. (2003) Suppression of β Cell Energy Metabolism and Insulin Release by PGC-1α. Developmental Cell 5: 73-83.
24. Puigserver P (2005) Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obes (Lond) 29 Suppl 1: S5-9.
25. Finck BN, Kelly DP (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116: 615-622.
26. Zhang PX, Liu C, Zhang CN, Zhang Y, Shen PP, et aL (2005) Free fatty acids increase PGC-1α expression in isolated rat islets. FEBS Letters 579: 1446-1452.
27. Richardson DK, Kashyap S, Bajaj M, Cusi K, Mandarino SJ, et al. (2005) Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 280: 10290-10297.
28. Lin JD, Yang RJ, Tarr PT, Wu PH, Handschin C, et al. (2005) Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 coactivation of SREBP. Cell 120: 261-273.
29. Staiger H, Staiger K, Haas C, Weisser M, Mathicao F, et. al. (2005) Fatty acid. induced differential regulation of the genes encoding peroxisome proliferator-activated receptor-gammol/La coactivator-1alpha and -1beta in human skeletal muscle cells that have been differentiated in vitro. Diabetologia 48: 2115-2118.
30. Coll T, Jove M, Rodriguez-Calvo R, Eyre E, Palomer X, et al. (2006) Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/ 2 and nuclear factor-kappaB activation. Diabetes 55: 2779-2787.
31. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, et al. (2007) Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem 282(21). 15439-15450.
32. Hondares E, Mora O, Yubero P, Rodriguez de la Concepción M, Iglesias R, et al. (2006) Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGG-1alpha expression in adipocytcs via peroxisome proliferator-activated receptor-gamma coactivation. Endocrinology 147(6): 2829-2838.
33. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, et al. (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52: 2461-2474.
34. Haourigui M, Martin ME, Thobie N, Benassayag C, Nunez EA (1993) Stimulation of the binding properties of adult rat corticosteroid-binding globulin by a lipolysis-induced rise in plasma free fatty acids. Endocrinology 138: 183-191.
35. Gaster M, Rustan AC, Beck-Nielsen H (2005) Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes 54: 648-656.
36. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
37. Davis RJ (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556.
38. Oda N, Abe M, Sato Y (1999) ETS-1 converts endothelial cells to the angiogenic phenotype by induciug the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 178: 121-132.
39. Staels B (2005) PPARgamma and atherosclerosis. Curr Med Res Opin 21 Suppl 1: S13-20.
40. Brown JD, Plutzky J (2007) Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 115(4): 518-533.
41. Sylvester AM, Chen D, Krasinski K, Andres V (1998) Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest 101: 940-948.
42. Galis Z, Muszynski M, Sukhova G, Simon-Morrissey E, Unemori E, et al. (1994) Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix degradation. Circ Res 75: 181-189.
43. Gordon D, Mohai LG, Schwartz SM (1986) Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ Res 59: 633-644.
44. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, et al. (1996) Efficient generation of recombinant adenoviruses using adenovius DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93: 1320-1324.
45. Marshall NJ, Goodwin CJ, Holt SJ (1995) A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul 5: 69-84.
46. Majack R, Clowes A (1984) Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 118: 253-256.
47. Sarkar R, Meinberg E, Stanley J, Gordon D, Webb R (1996) Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78: 225-230.
48. Grotendorst GR, Seppa HE, Kleinman HK, Martin GR (1981) Attachment of smooth muscle cells to collagen and their migration toward platelet derived growth factor. Proc Natl Acad Sci U S A 78: 3669-3672.
49. Majack RA, Clowes AW (1984) Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 118: 253-256.
50. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acid Res 19(9): 2499.